Related Experiment Video
Updated: Jul 30, 2025

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
Treat to Target Confers Enhanced Low Density Lipoprotein Cholesterol Reduction Compared With a Fire and Forget
Penelope P J Sucharitkul1, Nawaz Z Safdar2, Bethany Bracewell2
1The University of Leeds, School of Medicine, University of Leeds, Leeds LS2 9JT, UK; The Leeds Vascular Institute, Leeds General Infirmary, Leeds Teaching Hospitals NHS Trust, Great George Street, Leeds LS1 3EX, UK.
No abstract available in PubMed .
More Related Videos
09:15Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Angina IV: Management
Coronary Artery Disease IV: Preventive Measures